ACS chemical neuroscience molecule spotlight on fanapt

Research output: Contribution to journalShort survey

6 Scopus citations

Abstract

The new mixed dopamaine D2/serotonin 5-HT2A antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.

Original languageEnglish (US)
Number of pages1
JournalACS Chemical Neuroscience
Volume1
Issue number6
DOIs
StatePublished - Jun 16 2010

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Fingerprint Dive into the research topics of 'ACS chemical neuroscience molecule spotlight on fanapt'. Together they form a unique fingerprint.

  • Cite this